|
|
|
 |
|
|
|
| * |
|
Molecular characterization of commonly used cell lines for bone tumor research: A trans-European EuroBoNet effort.
Ottaviano L, Schaefer KL, Gajewski M, Huckenbeck W, Baldus S, Rogel U, Mackintosh C, de Alava E, Myklebost O, Kresse SH, Meza-Zepeda LA, Serra M, Cleton-Jansen AM, Hogendoorn PC, Buerger H, Aigner T, Gabbert HE, Poremba C.
Genes Chromosomes Cancer. 2009 Sep 29. [Epub ahead of print]
|
|
| * |
|
Ordóñez JL, Osuna D, Herrero D, de Alava E*, Madoz-Gúrpide J*. (* corresponding authors)
Advances in Ewing's sarcoma research: where are we now and what lies ahead?
Cancer Res 2009;69:7140-50 |
|
| * |
|
Osuna D, de Alava E.
Molecular pathology of sarcomas.
Rev Recent Clin Trials. 2009;4:12-26. Review |
|
| * |
|
Eefting D, Schrage YM, Geirnaerdt MJ, Le Cessie S, Taminiau AH, Bovée JV, Hogendoorn PC; EuroBoNeT consortium.
Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
Am J Surg Pathol 2009;33:50-7 |
|
| * |
|
Moyano S, Aguilera P, Petit A, de Alava E, Mascaró JM, Palou J, Ferrando J, Alos L.
Alveolar soft part sarcoma presenting with cutaneous metastases: report of a case with immunohistochemical and molecular characterization.
J Am Acad Dermatol. 2009 Jul;61(1):117-20 |
|
| * |
|
Herrero-Martín D. Osuna D. Ordóñez JL, Sevillano V, Martins AS, Mackintosh C, Campos M, Madoz-Gúrpide J, Otero-Motta AP, Caballero G, Amaral, AT, Wai DH, Braun Y, Eisenacher M, Schaefer KL, Poremba C, and de Alava E.
“Stable interference of EWS-FLI1 in a Ewing Sarcoma cell line impairs IGF-1/IGF-1R signaling and reveals TOPK as a novel target.
Br J Cancer. 2009;101:80-90 |
|
| * |
|
De Alava E, Ramón y Cajal S
EWS-FLI (ets) Fusion Transcripts
Encyclopedia of Cancer
Springer-Verlag Berlin Heidelberg New York 2008
DOI: 10.1007/978-3-540-47648-1_2046
http://www.springerlink.com/content/l761358j5rh87435/fulltext.html |
|
| * |
|
Ocio EM, Maiso P, Chen X, Garayoa M, Álvarez-Fernández S, San-Segundo L, Vilanova D, López-Corral L, Montero JC, Hernández-Iglesias T, de Álava E, Galmarini C, Avilés P, Cuevas C, San-Miguel, JF, Pandiella A
Zalypsis: A novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double strand breaks
Blood 2009;113:3781-91 |
|
| * |
|
de Alava E.
Targeted therapies and biological modifiers. Introduction.
Semin Diagn Pathol. 2008 Nov;25(4):231 (Editorial) |
|
| * |
|
Ordóñez JL, Martins AS, Osuna D, Madoz-Gúrpide J, de Alava E.
Targeting sarcomas: therapeutic targets and their rational.
Semin Diagn Pathol. 2008 Nov;25(4):304-16. |
|
| * |
|
Morente MM, Fernández PL, de Alava E
Biobanking: old activity or young discipline?
Semin Diagn Pathol. 2008 Nov;25(4):317-22. |
|
| * |
|
Castro E, de Alava E
The risk of taking the part by the whole. (Letter to the editor)
Ann Oncol. 2008; 19:1975-6 |
|
| * |
|
Llano E, Gómez R, Gutiérrez-Caballero C, Herrán Y, Sánchez-Martín M, Vázquez-Quiñones L, Hernández T, de Álava E, Cuadrado A, Barbero JL, Suja JA, Pendás AM.
Shugoshin-2 is essential for the completion of meiosis but not for mitotic cell division in mice
Genes and Development 2008; 22: 2400-2413. |
|
| * |
|
García de Marcos JA, del Castillo-Pardo de Vera JL, Poblet E, Galdeano-Arenas M, Arroyo-Rodríguez S, Calderón-Polanco J, de Alava E.
Clear cell sarcoma of the temporal region: case report, review of the literature, and genetic analysis.
J Oral Maxillofac Surg. 2009;67):910-4. |
|
| * |
|
Martins AS, Ordóñez JL, García-Sánchez A, Herrero D, Sevillano V, Osuna D, Mackintosh C, Caballero G, Otero-Motta AP, Poremba C, Madoz-Gúrpide J, de Alava E.
A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-IGF1R treatment: in vitro and in vivo study.
Cancer Research 2008; 68:6260-6270
|
|
| * |
|
Lavarino C, Garcia I, Mackintosh C, Cheung NKV, Domenech G, Ríos J, Perez N, Rodríguez E, de Torres C, Gerald WL, Tuset E, Acosta E, Beleta H, de Álava E, Mora J.
Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status.
BMC Med Genomics 2008;1:36. |
|
| * |
|
Espinosa AB, Mackintosh C, Maíllo A, Gutierrez L, Sousa P, Merino M, Ortiz J, de Alava E, Orfao A, Tabernero MD
Array-based comparative genomic hybridization of mapped BAC DNA clones to screen for chromosome
14 copy number abnormalities in meningiomas.
European Journal of Human Genetics 2008;16:1450-8
|
|
| * |
|
Casali PG, Jost L, Reichardt P, Schlemmer M, Blay JY; ESMO Guidelines Working Group.
Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Ann Oncol. 2008 May;19 Suppl 2:ii35-8.
|
|
| * |
|
Casali PG, Jost L, Sleijfer S, Verweij J, Blay JY; ESMO Guidelines Working Group.
Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Ann Oncol. 2008 May;19 Suppl 2:ii89-93.
|
|
| * |
|
Villamón E, Piqueras M, Mackintosh C, Alonso J, de Álava E, Navarro S, Noguera R
Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma.
Virchows Archivs 2008;453:47-55 |
|
| * |
|
Abdulkader I, Cameselle-Teijeiro J, de Alava E, Ruiz-Ponte C, Used-Aznar MM, Forteza J.
Intestinal clear cell sarcoma with melanocytic differentiation and extraskeletal myxoid chondrosarcoma rearrangement: report of a case.
Int J Surg Pathol. 2008;16:189-93.
Erratum en Int J Surg Pathol 2008; 16; 354
|
|
| * |
|
Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Munárriz B, Rodríguez CA, Crespo C, de Alava E, López García-Asenjo JA, Guitián MD, Almenar S, González-Palacios JF, Vera F , Palacios J, Ramos M, Gracia Marco JM, Lluch A, Alvarez I, Seguí MA, Mayordomo JI, Antón A, Baena JM, Plazaola A, Modolell A, Pelegrí A, Mel JR, Aranda E, Adrover E, Valero Álvarez J, García Puche JL, Sánchez-Rovira P, Gonzalez S, López-Vega JM.
Phase III Randomized Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel as Adjuvant Chemotherapy for Early Breast Cancer
Journal of the National Cancer Institute 2008;100: 805 – 814
|
|
| * |
|
Pardo J, Aisa G, de Alava E, Sola JJ, Panizo A, Rodríguez-Spiteri, García JL, Torre W.
Primary mixed squamous carcinoma and osteosarcoma (carcinosarcomas) of the lung have a CGH mapping similar to primitive squamous carcinomas and osteosarcomas.
Diagn Mol Pathol 2008;17:151–158 |
|
| * |
|
Morente MM, de Alava E, Fernandez PL.
Tumour Banking: The Spanish Design.
Pathobiology. 2007;74:245-50.
Indice de Impacto: 1,471
|
|
| * |
|
EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model
Author(s): Gonzalez I, Vicent S, de Alava E, et al.
Source: JOURNAL OF MOLECULAR MEDICINE-JMM Volume: 85 Issue: 9 Pages: 1015-1029 Published: 2007
|
|
| * |
|
Mixed squamous carcinoma and osteosarcoma (carcinosarcomas) of the lung have a CGH mapping similar to primitive squamous carcinomas and osteosarcomas
Author(s): Pardo J, De Alava E, Solal JJ, et al.
Source: VIRCHOWS ARCHIV Volume: 451 Issue: 2 Pages: 430-430 Published: 2007
|
|
| * |
|
Schaefer KL, Eisenacher M, Braun Y, Brachwitz K, Wai DH, Dirksen U, Lanvers-Kaminsky C, Juergens H, Herrero D, Stegmaier S, Koscielniak E, Eggert A, Nathrath M, Gosheger G, Schneider DT, Bury C, Diallo-Danebrock R, Ottaviano L, Gabbert HE, Poremba C. Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. Eur J Cancer. 2008 Feb.
|
|
| * |
|
Morilla Grasa-A, Caissie A.L., López R, Ordóñez JL, Saornil MA, Blanco G, Fernández N, Almaraz A, Burnier Jr. M. N
TÍTULO: Co-expresion of Vimentin and Cytokeratin in Uveal melanoma Cells: In Vitro and In Vivo Studies
REF. REVISTA/LIBRO: BJO 2007
|
|
| * |
|
Ordóñez JL, Saornil MA, Galarreta D, Morilla-Grasa A, Guinea J, Blanco G, Rábano G, Ramón y Cajal S.TÍTULO: Therapy with adenovirus dl118 in uveal melanoma: in vitro and in vivo studyREF. REVISTA/LIBRO: Cancer Gene Therapy 2006 |
|
| * |
|
de Alava E, Ocaña A, Abad M, Montero JC, Esparis-Ogando A, Rodríguez CA, Otero AP, Hernandez T, Cruz JJ, Pandiella A. Neuregulin expression modulates clinical response to Herceptin in patients with Metastatic Breast Cancer . J Clin Oncol. 2007 ;25:2656-63. Indice de Impacto: 13.59 Ranking 4/103 (Oncology)
|
|
| * |
|
Pardo J, Torres W, Martínez-Peñuela A, Panizo A, de Alava E, García JL
"Pseudomesotheliomatous carcinoma of the lung (PCL) with a distinct morphology, immunohistochemistry and CGH profile"
Annals of Diagnostic Pathology 2007
|
|
| * |
|
A proteomics analysis of cell signaling alterations in colorectal cancer
Author(s): Madoz-Gurpide J, Canamero M, Sanchez L, et al.
Source: MOLECULAR & CELLULAR PROTEOMICS Volume: 6 Issue: 12 Pages: 2150-2164 Published: 2007
|
|
| * |
|
Tejerina E, Corbacho C, López A, Bellas C, Sánchez V, Sánchez A, de Alava E, Sanz E.
Tumor intraabdominal desmoplásico de células pequeñas y redondas. Revisión de la literatura a propósito de un caso con estudio citológico, histopatológico, inmunohistoquímico y molecular.
Rev Esp Oncol 2007; 30: 25-31
|
|
| * |
|
de Alava E
Molecular pathology of sarcomas
Clin Transl Oncol. 2007;9:130-44.
|
|
| * |
|
Morente MM, de Alava E, Fernandez PL.
Bancos de tumores en España. Realidades y retos.
Oncología 2007
|
|
| * |
|
González I, Vicent S, de Alava E, Lecanda F.
EWS/FLI-1 Oncoprotein Subtypes Impose Different Requirements in Transformation and Metastatic Activity in a murine model.
J Mol Med 2007
Indice de Impacto: 4,702
Ranking 9/72 (Medicine, Research and Experimental)
|
|
| * |
|
Morente MM, de Alava E, Fernandez PL.
Tumour Banking: The Spanish Design.
Pathobiology 2007
Indice de Impacto: 1,471
|
|
| * |
|
Hiscott, P.; Paraoan, L.; Choudhary, A.; Ordonez, J. L.; Al-Khaiera, A.; Armstrong, D. J Thrombospondin 1, thrombospondin 2 and the eye. REF. REVISTA/LIBRO: Prog Retin Eye Res. 2006 Jan;25(1):1-18 |
|
| * |
|
Proteomics-based validation of genomic data - Applications in colorectal cancer diagnosis
Author(s): Madoz-Gurpide J, Lopez-Serra P, Martinez-Torrecuadrada JL, et al.
Source: MOLECULAR & CELLULAR PROTEOMICS Volume: 5 Issue: 8 Pages: 1471-1483 Published: 2006
|
|
| * |
|
Sayagués JM, Tabernero MD, Maíllo A, Trelles O, Espinosa AB, Sarasquete ME, Merino M, Rasillo A,Fernandez Vera J, Santos-Briz A, de Alava E, Garcia-Macias MC, Orfao A.
Microarray-based analysis of spinal vs intracranial meningiomas: different clinical, biological and genetic characteristics associated with distinct patterns of gene expression.
J Neuropathol Exp Neurol 2006;65:445-454.
Indice de Impacto: 4,471
Citaciones: 14
Ranking: 40/66 (Pathology)
|
|
| * |
|
Santos CR, Rodríguez-Pinilla M, Vega FM, Rodríguez-Peralto JL, Blanco S, Sevilla A, Valbuena A, Hernández T, van Wijnen A, Li F, de Alava E, Sánchez-Céspedes M, Lazo P.
The VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma.
Molecular Cancer Research 2006;4:177–85
Indice de Impacto: 5,417
Citaciones: 2
Ranking: 40/126 (Cell Oncology)
|
|
| * |
|
Martins AS, Mackintosh C, Herrero Martín D, Campos M, Hernández T, Ordóñez JL, de Alava E.
IGF1R pathway inhibition by ADW742, alone or in combination with Imatinib, doxorubicin or vincristine, is a novel therapeutic approach in Ewing Tumor.
Clinical Cancer Research 2006 ;12:3532-40.
Indice de Impacto: 5,715
Ranking: 14/123 (Oncology)
|
|
| * |
|
Lopez-Beltran A, Pérez-Seoane C, Montironi R, Hernández-Iglesias T, Mackintosh C, de Alava E.
Primary primitive neuroectodermal tumour of the urinary bladder: a clinico-pathologic study with emphasis on immunohistochemical, ultrastructural and molecular analysis.
J Clin Pathol 2006;59:775-8.
Indice de Impacto: 2,170 Ranking: 17/66 (Pathology)
|
|
| * |
|
Mendiola M, Carrillo J, García E, Lalli E, Hernández T, de Alava E, Tirode F, Delattre O, García-Miguel P, López-Barea F, Pestaña A, Alonso J.
The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumours.
Int J Canc 2006; 118:1381-1389
Indice de Impacto: 4,700
Ranking: 22/123 (Oncology)
|
|
| * |
|
Sauzeau V, Sevilla MA, Rivas-Elena JV, de Álava E, Montero MJ, López-Novoa JM, Bustelo XR.
vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and extensive cardiovascular disease.
Nature Medicine 2006; 12:841 - 845 |
|
| * |
|
Microarray-based analysis of spinal vs intracranial meningiomas: different clinical, biological and genetic characteristics associated with distinct patterns of gene expression.
Sayagués JM, Tabernero MD, Maíllo A, Trelles O, Espinosa AB, Sarasquete ME, Merino M, Rasillo A,Fernandez Vera J, Santos-Briz A, de Alava E, Garcia-Macias MC, Orfao A.
Journal Of Neuropathology And Experimental Neurology 2006;65:445-454
|
|
| * |
|
Santos CR, Rodríguez-Pinilla M, Vega FM, Rodríguez-Peralto JL, Blanco S, Sevilla A, Valbuena A, Hernández T, van Wijnen A, Li F, de Alava E, Sánchez-Céspedes M, Lazo P.
The VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma.
Molecular Cancer Research 2006;4:177 |
|
| * |
|
Martins AS, Mackintosh C, Herrero Martín D, Campos M, Hernández T, Ordóñez JL, de Alava E.
IGF1R pathway inhibition by ADW742, alone or in combination with Imatinib, doxorubicin or vincristine, is a novel therapeutic approach in Ewing Tumor.
Clinical Cancer Research 2006;12:3532-40.
|
|
| * |
|
López-Beltran A, Pérez-Seoane C, Montironi R, Hernández-Iglesias T, Mackintosh C, de Alava E.
Primary primitive neuroectodermal tumour of the urinary bladder: a clinico-pathologic study with emphasis on immunohistochemical, ultrastructural and molecular analysis.
J Clin Pathol 2006;59:775-8. |
|
| * |
|
Mendiola M, Carrillo J, García E, Lalli E, Hernández T, de Alava E, Tirode F, Delattre O, García-Miguel P, López-Barea F, Pestaña A, Alonso J.
The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumours.
Int J Canc 2006; 118:1381-1389
|
|
| * |
|
Bandres E, Malumbres R, Escalada A, Cubedo E, Gonzalez I, Honorato B, Zarate R, Garcia-Foncillas J, de Alava E.
Gene Expression Profile of Ewing Sarcoma Cell Lines Differing in Their EWS-FLI1 Fusion Type.
J Pediatr Hematol Oncol. 2005;27:537-542
|
|
| * |
|
Alzina de Aguilar V, Gaboli M, Bastero Minon P, Romero Montero A, de Alava E.
Neonatal respiratory failure associated with mutation in the surfactant protein C gene
An Pediatr (Barc) 2005;62:210-4.
|
|
| * |
|
Serrano C, Mackintosh C, Herrero D, Martins AS, Hernández T, Pérez-Fontán J, Pérez A, Serrano E, Orfao A, Bullón A, Abad M, de Álava E.
Imatinib is not a potential alternative treatment for uterine leiomyosarcomas.
Clinical Cancer Res 2005;11:4977-9 |
|
| * |
|
González I, Andreu EJ, Panizo A, Inogés S, Fontalba A, Fernández-Luna JL, Gaboli M, Sierrasesúmaga L, Martín-Algarra S, Pardo J, Prósper F, de Álava E.
Imatinib inhibits proliferation of Ewing tumor cells mediated by the Stem Cell Factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis.
Clin Canc Res 2004; 10: 751-761
|
|
| * |
|
Idoate MA, Soria E, Lozano MD, Sola JJ, Panizo A, de Álava E, Manrique M, Pardo-Mindan FJ.
PTEN protein expression correlates with PTEN gene molecular changes but not with VEGF expression in astrocytomas. Diagn Mol Pathol 2003;12:160-5
|
|
| * |
|
Panizo-Santos A, Sola I, de Álava E, Lozano MD, Idoate MA, Pardo FJ. Angiomyolipoma and PEComa Are Immunoreactive for MyoD1 in Cell Cytoplasmic Staining Pattern. Appl Immunohistochem Mol Morphol 2003;11:156-60.
|
|
| * |
|
de Álava E
Endometrial stromal tumors. Another translocation-associated tumor?
Adv Anat Pathol 2003;10: 48-49
|
|
| * |
|
de Álava E
Respuesta: Transcripts, transcripts everywhere.
Adv Anat Pathol 2002;9:265-7.
|
|
| * |
|
de Álava E
Diagnosis of small round cell tumors of bone.
Cur Diagn Pathol 2001; 7: 251-261.
|
|
| * |
|
de Álava E
Transcripts, transcripts everywhere
Adv Anat Pathol 2001;8:264-272.
|
|
| * |
|
de Álava E, Pardo J. Ewing tumor.
Tumor biology and clinical applications.
Int J Surg Pathol 2001; 9: 7-18.
|
|
| * |
|
de Álava E. Olfactory neuroblastoma (esthesioneuroblastoma). Does it belong to the Ewing sarcoma family of tumors?
Adv Anat Pathol 2000; 7:323.
|
|
| * |
|
Pardo J, Díaz L, Errasti P, Idoate M, de Álava E, Sola I, Lozano MD, Panizo A.
Mast cells in chronic rejection of human renal allografts
Virchows Arch 2000; 437: 167-172.
|
|
| * |
|
Lasso JM, España A, Zudaire MI, de Álava E, Bazan A.
Congenital infiltrating lipoma of the upper limb in a patient with von Willebrand disease.
Br J Dermatol. 2000;143:180-182.
|
|
| * |
|
Panizo A, Sola I, Lozano MD, de Álava E, Pardo J.
Metastatic osteosarcoma presenting as a small bowel polyp: case report and literature review.
Arch Pathol Lab Med 2000; 124:1682-4.
|
|
| * |
|
Wei G, Antonescu CR, de Álava E, Leung DH, Huvos AG, Meyers P, Healey JH, Ladanyi M.
Prognostic impact of INK4A deletion in Ewing'sarcoma
Cancer 2000;89: 793-799.
|
|
| * |
|
de Álava E, Antonescu CR, Panizo A, Leung DH, Meyers P, Huvos AG, Pardo-Mindan FJ, Healey JH, Ladanyi M.
Prognostic impact of p53 status Ewing sarcoma
Cancer 2000;89: 783-792.
|
|
| * |
|
de Álava E, Panizo A, Antonescu C, Ginsberg JP, Huvos AG, Pardo-Mindán FJ, Barr FG, Ladanyi M.
Association of EWS-FLI1 type 1 fusion with lower proliferative rate and lower expression of IGF1 receptor in Ewing's sarcoma.
Am J Pathol 2000; 156: 849-855
|
|
| * |
|
de Álava E, Sánchez-Prieto R, Ramon y Cajal S.
Adenovirus E1A and Ewing tumors. Nature Medicine 2000;6:4
|
|
| * |
|
de Álava E, Gerald WL.
Biology of Neoplasia. Ewing's sarcoma and related tumors. Tumor biology and clinical applications.
J Clin Oncol 2000;18 204-213
|
|
| * |
|
Castillo JE, Martínez-Ansó E, Malumbres R, de Álava E, García C, Medina JF, Prieto J.
In situ localization of anion exchanger-2 in the human kidney
Cell Tissue Res 2000; 299: 281-287.
|
|
| * |
|
Sánchez-Prieto R, de Álava E, Palomino T, Guinea J, Fernández V, Cebrián S, Lleonart M, Cabello P, Martín P, San Román C, Borstein R, Pardo FJ, Martínez A, Díaz-Espada F, Barrios Y, Ramón y Cajal S.
A novel association between viral genes and human oncogenic alterations. The adenovirus E1A induces the Ewing's tumor fusion transcript EWS-FLI1.
Nature Medicine 1999;5:1076-1079.
|
|
| * |
|
Pardo FJ, Errasti P, Idoate MA, Sola I, Lozano MD, de Álava E, Panizo A.
Apoptosis and proliferation index in renal biopsies with early chronic rejection and in biopsies from donors older than 60 years.
Transplant Proc. 1999;31:2283-4
|
|
| * |
|
Panizo A, Pardo FJ, Lozano MD, de Álava E, Sola I, Idoate MA.
Ischemic injury in post-transplant endomyocardial biopsies: immunohistochemical study of fibronectin.
Transplant Proc. 1999;31:2550-1
|
|
| * |
|
Patiño A, López de Mesa R, de Álava E, Sierrasesúmaga L.
Clinical and molecular features of Ewing's sarcoma in a patient with triple X syndrome.
Cancer Genet Cytogenet 1999;113:188-90
|
|
| * |
|
Pardo Mindan FJ, Errasti P, Panizo A, Sola I, de Álava E, Lozano MD.
Decrease of Apoptosis Rate in Patients with Renal TransplantationTreated with Mycophenolate Mofetil.
Nephron 1999;82:232-237
|
|
| * |
|
Ginsberg JP, de Álava E, Ladanyi M, Wexler LH, Kovar H, Paulussen M, Zoubek A, Dockhorn-Dworniczak B, Juergens H, Wunder JS, Andrulis I, Malik R, Sorensen PHB, Womer RB, Barr FG.
EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
J Clin Oncol 1999; 17:1809-1814
|
|
| * |
|
de Álava E, Lozano MD, Patiño A, Sierrasesúmaga L, Pardo-Mindán FJ.
Ewing Family tumors. Potential prognostic value of RT-PCR detection of minimal residual disease in peripheral blood samples.
Diagn Mol Pathol 1998;7:152-157
|
|
| * |
|
Gerald WL, Ladanyi M, de Álava E, Cuatrecasas M, Kushner BH, LaQuaglia MP, Rosai J.
Clinical, Pathologic, and Molecular Spectrum of Tumors Associated With t(11;22)(p13;q12): Desmoplastic Small Round-Cell Tumor and Its Variants.
J Clin Oncol 1998; 16:3028-3036.
|
|
| * |
|
Ordi J, de Álava E, Torné A, Mellado B, Iglesias X, Cardesa A.
Intra-abdominal desmoplastic small cell tumor with EWS/ERG fusion transcript
Am J Surg Pathol 1998; 22:1026-1032.
|
|
| * |
|
de Álava E, Kawai A, Healey JA, Fligman I, Meyers P, Huvos AG, Gerald WL, Jhanwar SC, Argani P, Antonescu CR, Pardo-Mindán FJ, Ginsberg J, Womer R, Lawlor E, Wunder J, Andrulis I, Sorensen PHB, Barr FG, Ladanyi M.
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
J Clin Oncol 1998; 16:1248-1255.
|
|
| * |
|
de Álava E, Panizo A, Sola I, Rodríguez-Rubio FI, Pardo-Mindán FJ.
CD 44 v6 expression is related to progression in renal epithelial tumours.
Histopathology 1998; 33:39-45.
|
|
| * |
|
de Álava E, Lozano MD, Sola JJ, Panizo A, Idoate MA, Forteza J, Sierrasesúmaga L, Pardo-Mindán FJ.
Molecular features in a biphenotypic small cell sarcoma with neuroectodermal and muscle differentiation.
Hum Pathol 1998; 29:181-184
|
|
| * |
|
Vanaclocha V, Sáiz-Sapena N, García-Casasola C, de Álava E.
Cranioplasty with autogenous autoclaved calvarial bone flap in the cases of tumoural invasion.
Acta Neurochir (Wien) 1997 ;139 :970-976.
|
|
| * |
|
de Álava E, Ladanyi M, Rosai J, Gerald WL.
Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by RT-PCR. A specific diagnostic assay.
Am J Pathol 1995;147:1584-1591
|
|
| * |
|
de Álava E, Ladanyi M, Rosai J, Gerald W.
Molecular characterization of the fusion gene EWS-WT1 in desmoplastic small round cell tumor
Oncology Reports 1995;2:964
|
|
| * |
|
Gerald W, Ladanyi M, de Álava E, Rosai J.
Desmoplastic small round cell tumor. A newly described entity with a unique gene fusion.
Adv Anat Pathol 1995;2:341-345.
|
|
| * |
|
Kazadi J, de Álava E, Jurado M.
Une tumeur rare du vagin: le léiomyosarcoma primaire. Apropos d'une observation
Revue Française de Gynécologie et d'Obstétrique 1995;90:222-227.
|
|
| * |
|
de Álava E, Panizo-Santos A, Fernández-González AL, Pardo-Mindán FJ.
Eosinophilic myocarditis in patients waiting for heart transplantation.
Cardiovasc Pathol 1995;4:43-46.
|
|
| * |
|
Camps J, García-Granero M, Riezu-Boj JI, Larrea E, de Álava E, Civeira MP, Castilla A, Prieto J.
Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon.
J Hepatol (Denmark) 1994;21:4-11.
|
|
| * |
|
de Álava E, Sola JJ, Lozano MD, Pardo-Mindán FJ.
Rhabdomyolysis and acute renal failure in a heart transplant recipient treated with hypolipidemiants.
Nephron 1994;66:242-243.
|
|
| * |
|
Kazadi-Buanga J, Villamizar N, de Álava E, Jurado M. Lymphome malin non hodgkinien a localisation ovarienne primaire. Reflexions a propos d'un cas. Rev Fr Gynecol Obstet 1993; 88: 104-107 |
|
| * |
|
Lecumberri F, Mansilla F, de Álava E, Iglesias A, Idoate F.
Linitis plástica de colon. Diagnóstico por TC y correlación patológica.
Revista de Cirugía Iberoamericana 1993;4:375-377.
|
|
| * |
|
Panizo A, de Álava E, Pardo-Mindán FJ.
Histological changes in the lung after successful treatment of primary lung carcinomas.
Arq Patol (Coimbra) 1993;25:17-22.
|
|
| * |
|
de Álava E, Torramadé J, Vázquez JJ. Case report. Leiomyosarcoma of the pancreas. Virchows Archivs A 1993;422:419-422. |
|
| * |
|
González-Manzano R, Vieitez JM, Tangco E, de Álava E, Herranz, P, García-Foncillas J. Phase II evaluation of doxorubicin, ifosfamide and dacarbazine plus amphotericine B (AIDAB) in the treatment of metastatic soft tissue sarcomas: a pilot study. Am J Clin Oncol 1993;16:332-337. |
|
| * |
|
de Villa VH, Cienfuegos JA, Hernández JL, Pardo F, Benito C, Balén E, Saez E, de Álava E
Primary nonfunction of porcine islets of Langerhans in the thymus of diabetic rats without immunosuppression.
Transplantation Proceedings 1992;24:2982-2983.
|
|
| * |
|
de Villa VH, Cienfuegos JA, Hernández JL, Pardo F, Benito C, Balén E, Saez E, de Álava E
Primary nonfunction of porcine islets of Langerhans in the thymus of diabetic rats without immunosuppression.
Transplantation Proceedings 1992;24:2982-2983.
|
|
| * |
|
de Álava E, Camps J, Pardo-Mindán FJ, García-Granero M, Muñoz M, Sola J, Civeira MP, Contreras F, Vázquez JJ, Castilla A, Prieto J.
Histological outcome of chronic hepatitis C after a twelve months course with alfa interferon.
Liver 1993;13:73-79.
|
|
| * |
|
Kazadi J, Villamizar N, de Álava E, Jurado M.
Lymphome malin non hodgkinien a localisation ovarienne primaire. Réflexions à propos d'un cas.
Revue Française de Gynécologie et d'Obstétrique 1993; 88:104-107.
|
|
| * |
|
Redondo P, Vázquez-Doval J, de Álava E, Quintanilla R.
White fibrous papulosis of the neck.
Dermatology 1993;186:238-239.
|
|
| * |
|
Cabañero J, Saenz de Buruaga J, Gómez JA, de Álava E, Llorens R, Martínez-Caro D.
Heart transplant in Ebstein´s anomaly with endocardial fibro-elastosis.
American Heart Journal 1992;124:532-534.
|
|
| * |
|
Pardo-Mindán FJ, Lozano MD, Contreras F, de Álava E.
Pathology of heart transplantation through endomyocardial biopsy.
Seminars in Diagnostic Pathology 1992;9:238-248
|
|
| * |
|
Camps J, García-Granero M, Riezu JI, Larrea M, de Álava E, Prieto J. Predictive factors of disease relapse after terapy with L-IFN in chronic hepatitis C.
Journal of Hepatology 1991;13:516.
|
|
|
|
|
|
|
Dr. Juan Jesús Cruz
Dr. Enrique de Álava